Taewoong Choi, MD Taewoong Choi, MD

Taewoong Choi, MD

Cell Therapy and Hematologic Malignancies Specialist

No ratings available.
question Circle Img
Duke Health Provider question Circle Img
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. More information will become available on PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans
Contact
919-668-1002 Office number
919-668-1091
Fax number
Insurance

Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.

Below are the plans currently accepted in 2018. There are some changes to the plans accepted beginning January 1, 2019. More information will become available on PlanForDuke.com.

Click to see a list of accepted insurance plansHide accepted insurance plans

Contact
WHERE I PROVIDE CARE
Profile
ABOUT ME

Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of Blood & Marrow Transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients.

LANGUAGES I SPEAK
English
LEARN MORE ABOUT ME
Training
EDUCATION
MD, Seoul National University (South Korea), 2002
RESIDENCY
Internal Medicine Residency, St. Luke Hospital (Chesterfield, MO), 2009-2012
FELLOWSHIP
Hematology/Oncology Fellowship Program, UPMC (Pittsburgh, PA), 2012-2015
BMT Fellowship Program, Stanford (Stanford, CA), 2015-2017
BOARD CERTIFICATION
American Board of Internal Medicine, Internal Medicine
American Board of Internal Medicine, Medical Oncology
American Board of Internal Medicine, Hematology
Clinical Focus and Research
MY RESEARCH INTERESTS

My previous research in immunology focused on the development of both human and murine natural killer (NK) cells. Specifically, I studied how NK cells develop tolerance and how NK cells develop their capacities. Recently, I have become interested in developing NK-based cellular therapy approach for hematologic malignancies in the setting of early phase clinical trials.

PUBLICATIONS
View Taewoong Choi's publications on PubMed
Industry Relationships and Collaborations
This faculty member has no reported relationships with industry.